Asia Pacific Impulse Oscillometry Market Analysis and Forecast by Size, Share, Growth, Trends 2034

Coverage: By Product (Device and Accessories), Device For Product (Desktop and Portable), Accessories For Product (Filters, Nose Clip, Support Arms, and Other Accessories), Application (Asthma, COPD, and Other Applications), and End User (Hospitals and Clinics, Diagnostic Laboratories, and Other End users)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Published
  • Report Code : TIPRE00043934
  • Category : Life Sciences
  • No. of Pages : 161
  • Available Report Formats : pdf-format excel-format
  • Last update date : July 31, 2026
Asia Pacific Impulse Oscillometry Market Analysis and Forecast by Size, Share, Growth, Trends 2034
Report Date: July 31, 2026   |   Report Code: TIPRE00043934 Email: sales@theinsightpartners.com

2025 Market Size

US$

Base year value

2034 Forecast

US$

Projected by 2034

CAGR 2026-2034

6.2 %

Growth rate

Addressable Market

US$ 149,215.95 THOUSAND

(2026-2034)

The Asia Pacific Impulse Oscillometry Market size is expected to reach US$ 20,711.7 Thousand by 2034 from US$ 12,126.2 Thousand in 2025. The market is estimated to record a CAGR of 6.2% from 2026 to 2034.

Executive Summary and Asia Pacific Impulse Oscillometry Market Analysis:

The Asia Pacific impulse oscillometry market is segmented into Japan, China, India, South Korea, Australia, and the Rest of the Asia Pacific. The rising prevalence of chronic respiratory diseases such as asthma and COPD is driven by urbanization, increasing air pollution, smoking, and aging populations in major markets such as China, India, and Japan. This prevalence has led hospitals, clinics, and diagnostic centers to adopt more sensitive and patient-friendly testing tools to improve early detection and disease management. IOS is noninvasive, requires minimal patient cooperation, and can detect small-airway dysfunction that traditional spirometry might miss, making it useful for pediatric and elderly patients and supporting broader clinical use across diverse patient groups. Manufacturers are introducing portable, integrated respiratory assessment systems that fit hospital and outpatient settings. Coupled with increasing healthcare expenditure and infrastructure development in emerging economies, this enhances access to sophisticated pulmonary function testing. Public awareness of respiratory health, bolstered by post-COVID-19 concerns and preventive screening initiatives, encourages earlier and more frequent use of advanced diagnostics such as IOS.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Asia Pacific Impulse Oscillometry Market: Strategic Insights

asia-pacific-impulse-oscillometry-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Asia Pacific Impulse Oscillometry Market Segmentation Analysis:

  • By Product, the Asia Pacific Impulse Oscillometry Market is segmented into Device and Accessories. The Device segment dominated the market in 2025.
  • By Device For Product, the Asia Pacific Impulse Oscillometry Market is segmented into Desktop and Portable. The Desktop segment dominated the market in 2025.
  • By Accessories For Product, the Asia Pacific Impulse Oscillometry Market is segmented into Filters, Nose Clip, Support Arms, and Other Accessories. The Filters segment dominated the market in 2025.
  • By Application, the Asia Pacific Impulse Oscillometry Market is segmented into Asthma, COPD, and Other Applications. The Asthma segment dominated the market in 2025.
  • By End User, the Asia Pacific Impulse Oscillometry Market is segmented into Hospitals and Clinics, Diagnostic Laboratories, and Other End users. The Hospitals and Clinics segment dominated the market in 2025.

Asia Pacific Impulse Oscillometry Market Report Scope

Report Attribute Details
Market size in 2025 US$ 12,126.2 Thousand
Market Size by 2034 US$ 20,711.7 Thousand
CAGR (2026 - 2034) 6.2%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Product
  • Device
  • Accessories
By Device For Product
  • Desktop
  • Portable
By Accessories For Product
  • Filters
  • Nose Clip
  • Support Arms
  • Other Accessories
By Application
  • Asthma
  • COPD
  • Other Applications
Regions and Countries Covered Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
Market leaders and key company profiles
  • COSMED Srl
  • Chest MI Inc
  • Morgan Scientific Inc
  • THORASYS Thoracic Medical Systems Inc.
  • Jaeger Medical GmbH
  • GANSHORN Medizin Electronic GmbH
  • Vitalograph Ltd
  • Lothar Medical GmbH
  • Cognita Labs, LLC
  • RESTECH srl

Asia Pacific Impulse Oscillometry Market Players Density: Understanding Its Impact on Business Dynamics

The Asia Pacific Impulse Oscillometry Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

asia-pacific-impulse-oscillometry-market-cagr

Asia Pacific Impulse Oscillometry Market Outlook

Expansion in emerging markets offers potential for IOS adoption, particularly in regions with rising respiratory disease burdens and limited access to traditional spirometry. In China, a multicenter cross-sectional study across 19 hospitals developed reference equations for IOS indices in healthy adults aged 18-90, establishing the R5 lower limit of normal at 0.17 kPa/L/s for males, facilitating localized diagnostics. South Korea's Seoul Metropolitan Government-Seoul National University Boramae Medical Center conducted retrospective analyses on 480 patients, differentiating COPD with IOS parameters such as Fres at 9.04 Hz, showing 85.6% sensitivity for small airway dysfunction detection. In India, oscillometry's effort-independent nature aligns with high asthma prevalence, as noted in Karnataka Pediatric Journal reviews emphasizing its role in tidal breathing assessments for underserved populations. A scoping review in PMC, covering Asian populations, revealed divergences in reference equations, with studies on 264 median subjects per group underscoring the need for region-specific models to improve accuracy in Asia. Brazilian and Middle Eastern expansions are implied through global initiatives. However, Chinese validations in 15,113 patients predicted FEV1/FVC ratios with an AUC of 0.822, validating IOS for COPD screening in resource-limited settings.

Educational campaigns highlighting IOS's advantages in precise, effort-independent lung function testing can build trust among healthcare providers, leading to sustained growth. By focusing on affordability and localization, firms can capitalize on the rising demand for innovative diagnostics amid ongoing healthcare reforms, ultimately boosting penetration and long-term revenue streams in these vibrant markets.

Asia Pacific Impulse Oscillometry Market Country Insights

By country, the Asia Pacific Impulse Oscillometry Market is segmented into China, Japan, India, Australia, South Korea, and the Rest of APAC. China held the largest share in 2025.

Respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD) place a heavy load on public health in China, where impulse oscillometry (IOS) serves as a practical, effort-independent method to evaluate airway function. This makes it especially helpful for children, older adults, and patients who struggle with standard spirometry. According to the World Health Organization (WHO) 2023 data, ~100 million people are affected by COPD in the country, accounting for ~25% of all COPD cases worldwide. According to "The Epidemiology of Asthma in Mainland China," published in October 2024, the overall prevalence of asthma was 2.20% in the country. High exposure to air pollution, smoking, and biomass fuels contributes to these numbers. IOS is recognized in Chinese clinical research and practice for its ability to assess small airway dysfunction and respiratory impedance during quiet breathing without the patient effort required for spirometry, improving detection in populations with airflow limitation that conventional tests may miss.

Recent research has advanced IOS use through multicenter studies that compare its parameters with traditional lung function tests and develop prediction equations for abnormal FEV1/FVC ratios in Chinese populations. Investigators have examined IOS-defined small airway dysfunction as a treatable trait in mild-to-moderate COPD, linking it to faster lung function decline and more exacerbations. In children with asthma, IOS combined with bronchodilator testing has improved management insights. These studies highlight growing clinical interest in IOS to support timely diagnosis and monitoring amid China's large respiratory disease burden. Examples include its application in bronchodilator response testing and monitoring lung function decline in rural and urban cohorts at the First Affiliated Hospital of Guangzhou Medical University. IOS complements spirometry in preschool wheezing and exercise-induced bronchoconstriction assessments, offering real-time resistance data. These advancements stem from collaborative efforts in respiratory centers, improving diagnostic precision in a population with high COPD prevalence driven by smoking and environmental factors.

Asia Pacific Impulse Oscillometry Market Company Profiles

Some of the key players operating in the market include COSMED Srl, Chest MI Inc, Morgan Scientific Inc, THORASYS Thoracic Medical Systems Inc., Jaeger Medical GmbH, GANSHORN Medizin Electronic GmbH, Vitalograph Ltd, Lothar Medical GmbH, Cognita Labs, LLC, and RESTECH srl.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Asia Pacific Impulse Oscillometry Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

  • Company websites, annual reports, financial statements, broker analyses, and investor presentations
  • Industry trade journals and other relevant publications
  • Government documents, statistical databases, and market reports
  • News articles, press releases, and webcasts specific to companies operating in the market

Note:

All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

  • Validate and refine findings from secondary research
  • Enhance the expertise and market understanding of the analysis team
  • Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

  • Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
  • External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA